Bharat Biotech's Covaxin Receives GMP Certificate From Hungary
Good Manufacturing Practices (GMP) compliance certificate from Hungary has been granted to Bharat Biotech’s Covid-19 vaccine Covaxin. The company on August 6 took to Twitter saying, “This marks the 1st EUDRAGDMP compliance certificate received by Bharat Biotech from European regulators.” The company stated that it aims to submit its documentation across the globe for emergency use authorization. Besides, it has been registered on the EUDRAGMDP database.